Cover Image

Clinical Study of Paliperidone Palmitate Long-Acting Injection Combined With Electroacupuncture in the Treatment of Methamphetamine Addicts

Objective: To explore the clinical efficacy of paliperidone palmitate long-acting injection combined with electroacupuncture in the treatment of methamphetamine addicts.Methods: This study focused on methamphetamine addicts who were admitted to our hospital from January 2020 to December 2020 as the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu Chen (Author), Mingchao Li (Author), Qiuming Ji (Author), Zou Su (Author), Ziyu Yang (Author), Yin Xu (Author), Qian Chen (Author), Dan Liao (Author), Jihua Zeng (Author), Yuhong Yang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation
by: Olivier Corbeil, et al.
Published: (2022)

Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan
by: Mahlich J, et al.
Published: (2015)

Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate
by: Katy Mason, et al.
Published: (2021)

Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
by: Sam Debaveye, et al.
Published: (2019)

Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension
by: Ric M Procyshyn, et al.
Published: (2020)

The use of concurrent long-acting injectable antipsychotic therapy with paliperidone palmitate and aripiprazole monohydrate in a patient with schizophrenia
by: Christopher Evernden, BSc, BScPharm, ACPR, et al.
Published: (2021)

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
by: Trevor A. Stump, PharmD, BCPP, et al.
Published: (2021)

Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting
by: Hodgson RE
Published: (2019)

Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations
by: Daniel Fife, et al.
Published: (2022)

Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting [Corrigendum]
by: Hodgson RE
Published: (2019)

Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study
by: Juan Antonio García-Carmona, et al.
Published: (2023)

Comparison of Paliperidone Palmitate from Different Crystallization Processes and Effect on Formulations In Vitro and In Vivo
by: Junfeng Shi, et al.
Published: (2022)

Cost-utility analysis of using paliperidone palmitate in schizophrenia in China
by: Rui Luo, et al.
Published: (2023)

Partial compliance with long-acting paliperidone palmitate and impact on hospitalization: a 6-year mirror-image study
by: Sofia Pappa, et al.
Published: (2020)

Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia
by: Ibrahim Turkoz, et al.
Published: (2023)

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
by: Charmi Patel, et al.
Published: (2019)

A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder
by: Chue P, et al.
Published: (2016)

An accidental household outbreak of paliperidone palmitate poisoning via pancake consumption in Lianyungang, China
by: Tinglu Zhang, et al.
Published: (2020)

Impact of traditional versus nontraditional initiation dosing schedule of paliperidone palmitate on 30-day readmission and safety
by: Erika Kim, PharmD, BCPP, et al.
Published: (2023)

Healthcare Resource Utilization and Costs Among Patients With Schizophrenia Switching From Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis
by: Charmi Patel, MPH, RN, et al.
Published: (2020)

Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia
by: Maria Paz Garcia-Portilla, et al.
Published: (2020)

Epigenetic mechanisms involved in methamphetamine addiction
by: Hang Wang, et al.
Published: (2022)

Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis
by: Christophe Sapin, et al.
Published: (2016)

Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia
by: Carpiniello B, et al.
Published: (2016)

Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes
by: Katalin Pungor, et al.
Published: (2020)

MicroRNAs in Methamphetamine-Induced Neurotoxicity and Addiction
by: Bi Deng, et al.
Published: (2022)

Clinical effectiveness of paliperidone palmitate 3‐monthly and 1‐monthly as monotherapy in patients with schizophrenia: A retrospective cohort study based on the Medicaid claims database
by: Chih‐Lin Chiang, et al.
Published: (2024)

Paliperidone to Treat Psychotic Disorders
by: Hormazd D. Minwalla, et al.
Published: (2021)

Neurotransmitters and Cardiovascular Responses to Aerobic and Resistance Exercise in Men Addicted to Methamphetamine
by: Hamid Arazi, et al.
Published: (2018)

Injection preparation filtration and health concerns among indigenous people who inject methamphetamine
by: Michael Anastario, et al.
Published: (2024)

Long-Acting Paliperidone Parenteral Formulations Based on Polycaprolactone Nanoparticles; the Influence of Stabilizer and Chitosan on In Vitro Release, Protein Adsorption, and Cytotoxicity
by: Mohammed Elmowafy, et al.
Published: (2020)

Electroacupuncture Reduces Anxiety Associated With Inflammatory Bowel Disease By Acting on Cannabinoid CB1 Receptors in the Ventral Hippocampus in Mice
by: Xue-Fei Hu, et al.
Published: (2022)

Fetal Meconium Peritonitis Associated with Prenatal Methamphetamine Exposure
by: Wen-Jui Yang, et al.
Published: (2005)

Engineering cocrystals of Paliperidone with enhanced solubility and dissolution characteristics
by: Radha-Rani Earle, et al.
Published: (2021)

The mechanism of electroacupuncture for depression on basic research: a systematic review
by: Xuke Han, et al.
Published: (2021)

Clinical application of electroacupuncture in enhanced recovery after surgery
by: Yu Mao, et al.
Published: (2023)

Comparison of Demographic Characteristics of Methamphetamine versus Opioid Users in The Addiction Treatment Center: A Case Study
by: Mahdieh Ebrahiminia, et al.
Published: (2017)

Cellular messenger molecules mediating addictive drug-induced cognitive impairment: cannabinoids, ketamine, methamphetamine, and cocaine
by: Hye In Sim, et al.
Published: (2022)

The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States
by: Sarah Mars, et al.
Published: (2024)

Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study
by: Montaner Julio SG, et al.
Published: (2006)